Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 27;8(5):954-967.
doi: 10.1016/j.ekir.2023.02.1082. eCollection 2023 May.

Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group

Affiliations

Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group

Ricardo Correa-Rotter et al. Kidney Int Rep. .

Abstract

Chronic kidney disease (CKD) represents a major challenge for Latin American (LatAm) because of its epidemic proportions. Therefore, the current status and knowledge of CKD in Latin America is not clearly understood. Moreover, there is a paucity of epidemiologic studies that makes the comparison across the countries even more difficult. To address these gaps, a virtual kidney expert opinion meeting of 14 key opinion leaders from Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, and Panama was held in January 2022 to review and discuss the status of CKD in various LatAm regions. The meeting discussed the following: (i) epidemiology, diagnosis, and treatment of CKD, (ii) detection and prevention programs, (iii) clinical guidelines, (iv) state of public policies about diagnosis and management of chronic kidney disease, and (v) role of innovative therapies in the management of CKD. The expert panel emphasized that efforts should be made to implement timely detection programs and early evaluation of kidney function parameters to prevent the development or progression of CKD. Furthermore, the panel discussed the importance of raising awareness among health care professionals; disseminating knowledge to the authorities, the medical community, and the general population about the kidney and cardiovascular benefits of novel therapies; and the need for timely updating of clinical practice guidelines, regulatory policies, and protocols across the region.

Keywords: chronic kidney disease; clinical practice guidelines; kidney failure; kidney replacement therapy; national kidney failure registries; national policies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of CKD in Latin America. Adapted from Wainstein et al.: ISN-GKHA: Latin America.
Figure 2
Figure 2
Patient journey and role of HCPs. CKD, chronic kidney disease; HCP, health care professional; KF, kidney failure; OTC, over-the-counter; PCP, primary care physician.
Figure 3
Figure 3
Proceedings of kidney expert opinion meet 2022–a stepwise approach. CKD, chronic kidney disease; KOL, key opinion leaders; LatAm, Latin America.
Figure 4
Figure 4
Some described opportunities for improving CKD detection and prevention programs. CKD, chronic kidney disease; MOH, Ministry of Health; PCP, primary care physician; SENASA, National Health Insurance; SISALRIL, Superintendent of Health and Labor Risks; SINAVE, National Epidemiologic Surveillance System; SNS, National Health Service. aA successful pilot program that links the PCPs alongside the nephrologists through a predefined questionnaire that should be filled by the PCPs and send to the nephrology department where the nephrologists take <3 days to revert.
Figure 5
Figure 5
Overall analysis (percentage) of CKD situation in the participating countries. CKD, chronic kidney disease; LatAm, Latin America. aArgentina, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama.

References

    1. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147. doi: 10.7326/0003-4819-139-2-200307150-00013. - DOI - PubMed
    1. Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One. 2016;11 doi: 10.1371/journal.pone.0158765. - DOI - PMC - PubMed
    1. Bikbov B., Purcell C.A., Levey A.S. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed
    1. Foreman K.J., Marquez N., Dolgert A., et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5. - DOI - PMC - PubMed
    1. Xie Y., Bowe B., Mokdad A.H., et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–581. doi: 10.1016/j.kint.2018.04.011. - DOI - PubMed

LinkOut - more resources